BF Biosciences Limited (PSX:BFBIO)

Pakistan · Delayed Price · Currency is PKR

138.35

+7.53 (5.76%)

At close: Apr 1, 2026

Revenue by Segment

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Pharmaceuticals	5.84B	3.66B	1.81B	-	-
Pharmaceuticals Growth	59.55%	102.19%	-	-	-
Total	5.84B	3.66B	1.81B	-	-
Total Growth	59.55%	102.19%	-	-	-

Revenue by Geography

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Pakistan	5.72B	3.61B	1.77B	1.05B	-
Pakistan Growth	58.70%	103.92%	68.60%	-	-
Export	-	-	-	471.00M	-
Nepal	39.08M	33.89M	30.49M	-	-
Nepal Growth	15.32%	11.16%	-	-	-
Afghanistan	32.51M	-	-	-	-
Mauritania	17.80M	-	-	-	-
Switzerland	16.82M	-	-	-	-
Sri Lanka	-	8.44M	5.72M	-	-
Sri Lanka Growth	-	47.46%	-	-	-
Others	7.61M	9.90M	4.72M	-	-
Others Growth	-23.15%	109.91%	-	-	-
Total	5.84B	3.66B	1.81B	1.52B	-
Total Growth	59.55%	102.19%	19.05%	-	-

Source: S&P Global Market Intelligence.